Navigation Links
Do the Europeans turn ill sitting up so late?

An extensive EU-financed sleep research project is coordinated from FinlandIn spring 2005 a large European research and training network was establishedto investigate the causes and implications of poor sleep from the medical as well as from the social point of view. This EU-financed sleep research project, named"The biomedical and sociological effects of sleep restriction" will last for four yearsand is coordinated by Dr. Tarja Porkka-Heiskanen (Stenberg) MD, PhD, at theUniversity of Helsinki, Institute of Biomedicine.

The objective of this sleep restriction research is to characterize the physiological and behavioural effects of sleep loss and its social consequences. Sleep loss can be a consequence of sleep disorders, shift work, socio-economic constraints or voluntary restriction of sleep, due to life style. This can result in performance decrements, mood disorders, increased accident rates and considerable decrease in the quality of life.Sleep loss may also predispose individuals to conditions such as burn-out and cardiovascular diseases.

The EU has granted a 4,4 million Euro funding for this research project from the Marie Curie 6th Framework Program. In addition to Finland there are partners from UK, Belgium, Germany and Switzerland.

Many countries are involved in sleep research, but especially in the smaller countries it is very difficult to acquire the funding. This sleep restriction project brings together researchers from five countries, thus creating an efficient network where the special skills of each partner can be utilized.

The network will provide funding for 24 doctoral and post-doctoral researchers.A high level research training program is created in cooperation with the European universities, graduate schools and sleep research societies.

Dr. Tarja Porkka-Heiskanen (Stenberg) says:"We can choose relevant courses from the available universities, schools and research societies and provide the trainees with a versatile education. The main objective of the training is that the trainees acquire a wide international knowledge as well in basic research as in experimental and clinical research, and also in epidemiology and sociology. Simultaneously the trainees learn to work in an international research environment and can benefit from the large research network in the future."


'"/>

Source:University of Helsinki


Related biology news :

1. Biologists discover why 10% of Europeans are safe from HIV
2. First-time analysis reveals millions of Europeans left at risk from influenza
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology: